Thomas White International LTD Takeda Pharmaceutical CO LTD Transaction History

Thomas White International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$13.02 - $20.31 $1.1 Million - $1.72 Million	-84,485 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$16.88 - $20.83 $55,670 - $68,697	-3,298 Reduced 3.76%	84,485 $1.67 Million
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $29,748 - $33,137	-1,842 Reduced 2.06%	87,783 $1.51 Million
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $156,598 - $193,528	-9,445 Reduced 9.53%	89,625 $1.59 Million
Q1 2019 May 08, 2019	BUY	$16.7 - $21.52 $1.65 Million - $2.13 Million	99,070 New	99,070 $2.02 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Thomas White International LTD, based on Form 13F filings with the SEC.

Stay updated on Thomas White International LTD with notifications on news.